北京商报讯(记者丁宁)1月6日晚间，伟思医疗(688580)发布公告称，公司股票连续三个交易日内收盘价 格涨幅偏离值累计超过30%，属于股票交易异常波动。 因涉及脑机接口概念，伟思医疗已连续两个交易日涨停收盘，截至1月6日收盘，伟思医疗报69.7元/ 股，涨幅为20.01%。 伟思医疗表示，公司主营业务聚焦于康复医疗器械的研发、生产与销售，产品广泛应用于精神康复、盆 底及产后康复、神经康复等领域。截至2025年末，公司在脑机接口领域的新产品仍处于市场培育初期， 主要布局非侵入式技术路线，与当前国际领先的侵入式脑机接口存在显著技术路径差异，相关产品尚未 实现规模化销售，对整体营业收入的贡献仍较为有限。 ...

Market Performance - The market saw over 4,100 stocks rise, with more than 100 stocks hitting the daily limit up. The Shanghai Composite Index closed at 4,083.67 points, up 1.50%, marking a 13-day consecutive rise, the longest since March 1992. It also surpassed the previous high of 4,034.08 points from November 14, 2025, reaching a new high in over ten years [1] - The Shenzhen Component Index rose by 1.40%, while the ChiNext Index increased by 0.75% [1] Trading Volume - The total trading volume for the day was approximately 28.3 trillion yuan, an increase of 265 billion yuan compared to the previous day [3] Market Drivers - According to Zhongyin Securities, the main factors supporting the market's upward trend include the increasing attractiveness of RMB assets and expectations for early-year credit issuance and subsequent policies. The corporate profit structure has positively changed, with new economic forces represented by advanced manufacturing and overseas enterprises driving the stabilization and recovery of A-share returns, providing solid fundamental support for the market [3] Sector Highlights - The brain-computer interface concept performed actively on the first trading day of 2026, with related stocks continuing to rise, surpassing their highest levels from 2025. Notably, BeiYikang hit the daily limit up of 30%, while WeiSi Medical and Sanbo Brain Science also saw significant gains [4] - The brain-computer interface industry is expanding from medical necessities into AI applications and robotics. Elon Musk has indicated that with advancements in Neuralink technology, there is potential for remote control of robots through thought, creating an ultimate ecosystem of "human brain + robot" [4] - The titanium dioxide sector has shown strong performance, with multiple stocks hitting the daily limit up. The industry recently issued a price increase notice to reverse previous low profitability, indicating a potential recovery window for industry profits. Leading companies like Longbai Group are expanding overseas, which may enhance the industry's position and international influence [5] - The commercial aerospace sector has also seen explosive growth, with over ten constituent stocks hitting the daily limit up [5] - The financial sector collectively surged, with Huayin Securities and Dazhihui hitting the daily limit up [6]

从资金流向上来看，当日医疗器械板块主力资金净流出13.5亿元，游资资金净流入4.26亿元，散户资金净 流入9.24亿元。医疗器械板块个股资金流向见下表： 证券之星消息，1月6日医疗器械板块较上一交易日上涨1.43%，伟思医疗领涨。当日上证指数报收于 4083.67，上涨1.5%。深证成指报收于14022.55，上涨1.4%。医疗器械板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 688580 | 伟恩医疗 | 69.70 | 20.01% | 10.29万 | | 6.98 亿 | | 688626 | 翔宇医疗 | 87.12 | 20.00% | 8.63万 | | 7.42亿 | | 300753 | 爰朋医疗 | 39.96 | 20.00% | 15.74万 | | 6.19亿 | | 301363 | 美好医疗 | 34.63 | 19.99% | - 3.91万 | | 1.36亿 | | 688273 | 麦澜德 | 61.22 | 19.9 ...

（文章来源：每日经济新闻） 每经AI快讯，1月6日，Wind数据显示，A股市场共计144只个股涨停。其中脑机接口板块多股连板，伟 思医疗、翔宇医疗等多股2连板。 ...

Market Overview - The A-share market continued to rise, with the Shanghai Composite Index achieving a 13-day winning streak, closing at 4083 points, up 1.5% [1] - The total market turnover reached 2.83 trillion yuan, an increase of 265 billion yuan from the previous trading day, with over 4100 stocks rising and nearly 150 stocks hitting the daily limit [1] Sector Performance - The brain-computer interface sector saw significant gains, with stocks like Sanbo Brain Science and Weisi Medical hitting the daily limit [2][4] - The titanium dioxide sector also experienced a collective price increase, with companies like Anning Shares and Vanadium Titanium Shares reaching the daily limit [2][6] - Brokerage stocks rose, with Huashan Securities and Hualin Securities hitting the daily limit [2][8] - Other sectors that performed well included industrial metals, silicon energy, electronic paper, and chemical raw materials [2] Brain-Computer Interface Sector - The brain-computer interface sector was particularly strong, with stocks like Beiyikang and Weisi Medical seeing gains of around 20% [5] - Elon Musk announced that Neuralink, his brain-computer interface company, plans to start large-scale production in 2026, which has positively impacted the sector [4] Titanium Dioxide Sector - The titanium dioxide industry recently issued a price increase notice to reverse previous low pricing and low profitability, indicating a potential recovery in industry profits [6] - Major domestic titanium dioxide companies are accelerating the layout of chloride process capacity, with Tianyuan Co. announcing a 1.48 billion yuan investment in a new project [6] Brokerage Sector - The brokerage sector is benefiting from high market activity, with the Shanghai Composite Index recording a 12-day winning streak and turnover exceeding 1 trillion yuan [8] - Analysts suggest that the improved policy environment and influx of funds will enhance the investment value of the brokerage sector, supporting growth in wealth management and self-operated business revenues [8] Industrial Metals Sector - The industrial metals sector is experiencing price increases driven by both financial and commodity attributes, with low global copper and aluminum inventories and expected demand growth from the recovering Chinese economy [12] - Stocks like Liyuan Shares and Chang Aluminum have seen significant gains, with some hitting the daily limit [13] Electronic Paper Sector - The electronic paper sector is also on the rise, with Su Dawei and other companies achieving substantial gains following a collaboration announcement with Shanghai Yudi Optoelectronics [14][15]

另外，马斯克近日在社交媒体上表示，其脑机接口公司Neuralink将于2026年开始对脑机接口设备进 行"大规模生产"。 | 代码 | 名称 | | 涨幅% ↓ | 总市值 | 年初至今涨幅% | | --- | --- | --- | --- | --- | --- | | 688580 | 伟思医疗 | 1 | 20.01 | 66.75亿 | 44.01 | | 301293 | 三博脑科 | 1 | 20.01 | 175亿 | 44.01 | | 688626 | 翔宇医疗 | 1 | 20.00 | 139亿 | 44.00 | | 300753 | 爰朋医疗 | 1 | 20.00 | 50.37 乙 | 44.00 | | 301330 | 熵基科技 | 1 | 19.99 | 112亿 | 43.99 | | 301363 | 美好医疗 | 1 | 19.99 | 197亿 | 43.99 | | 688273 | 麦澜德 | 1 | 19.99 | 61.22 亿 | 43.98 | | 300430 | 诚益通 | 1 | 18.47 | 74.60亿 | 42.14 | | 30040 ...

Market Performance - The Shanghai Composite Index rose by 1.14% to 4069.38 points, reaching a new high in over 10 years [1] - The Shenzhen Component Index increased by 0.81% to 13940.24 points, while the ChiNext Index fell by 0.04% to 3293.18 points [1] - The total trading volume in the Shanghai and Shenzhen markets was 178.13 billion yuan, with over 3600 stocks rising [1] Sector Performance - The leading sectors included brain-computer interfaces, chemical engineering, non-ferrous metals, insurance, securities, semiconductors, and photovoltaic equipment [2][3] - The non-ferrous metals sector saw a significant increase of 4.05%, while non-bank financials and oil & petrochemicals rose by 3.27% and 2.95%, respectively [3] - The brain-computer interface sector experienced a surge, with multiple stocks hitting the daily limit [3] Institutional Insights - Huatai Securities anticipates a strengthening spring market, recommending investments in growth sectors such as electric equipment and renewable energy, as well as domestic demand improvement themes [4] - CITIC Securities suggests that the cross-year market will exhibit characteristics of "growth leading and liquor accumulating," with a focus on sectors like snacks and dairy [5] - Guoxin Securities predicts that 2026 will be a significant year for the market, supported by favorable macro policies and improving corporate earnings [6] Emerging Opportunities - Guoxin Securities highlights the potential for 2026 to be the year of reusable commercial rockets, driven by the need for cost-effective launch solutions [7] - Tianfeng Securities expresses optimism about the growth potential in high-end consumer sectors such as cosmetics, gold jewelry, and duty-free shopping [8]

本报记者 刘钊 1月6日开盘，A股脑机接口概念板块延续强势，多只个股快速封板。截至记者发稿，其中伟思医疗（688580.SH）、三 博脑科（301293）（301293.SZ)、翔宇医疗（688626.SH）、爱朋医疗（300753）（300753.SZ)、美好医疗（301363） （301363.SZ）等多只个股20cm涨停，麦澜德（688273.SH）、诚益通（300430）（300430.SZ）、熵基科技 （301330）（301330.SZ）、博拓生物（688767.SH）等多只个股涨幅居前。 | 물을 | 代码 | 名称 | | 最新 | 涨幅% ↓ | 涨跌 | 成交量 | | --- | --- | --- | --- | --- | --- | --- | --- | | 1 | 688580 | 伟思医疗 | 1 | 69.70 | 20.01 | 11.62 | 8.70万 | | 2 | 301293 | 三博脑科 | 1 | 84.94 | 20.01 | 14.16 | 2.63万 | | 3 | 688626 | 翔宇医疗 | 1 | 87.12 | 20.00 | 14.52 | ...

Core Viewpoint - The stock of Weisi Medical has experienced a consecutive two-day limit-up, indicating strong market interest and performance in the brain-computer interface sector [1] Group 1: Stock Performance - Weisi Medical's stock reached a limit-up at 9:51 AM today, with a trading volume of 603 million yuan and a turnover rate of 9.32% [1] Group 2: Company Developments - The company has accumulated technology in the brain-computer interface field, including video EEG signal synchronization and automatic recognition of multi-channel EEG caps [1] - The performance for Q3 2025 shows positive growth in both revenue and net profit year-on-year [1] - The sale of the old headquarters has helped to optimize the asset structure and recover funds [1] - The rehabilitation equipment fundraising project has been completed with surplus funds used to supplement working capital [1] Group 3: Market Trends - The recent increase in activity within the brain-computer interface sector is attributed to technological breakthroughs and policy support, positioning it as a new economic growth point [1]

1月6日盘中科创板股伟思医疗涨停，截至09:54，股价报69.70元，成交5.86亿元，换手率9.06%，振幅 10.00%。 科创板个股中，截至发稿上涨的有405只，下跌的有190只，涨停的有伟思医疗、翔宇医疗等，跌幅居前 的有新光光电、华曙高科、兴图新科等，分别下跌8.64%、8.30%、5.50%。 资金面上，伟思医疗上一交易日主力资金净流入7765.42万元，近5日净流入8384.72万元。 融资融券数据显示，该股最新（1月5日）两融余额为2.02亿元，其中，融资余额为2.02亿元，较上一个 交易日增加2034.02万元，增幅为11.21%；融券余额为15.10万元，较上一个交易日增加5.42万元，增幅 为56.00%。近10日两融余额合计增加2458.46万元，增幅为13.87%，其间融资余额增长13.89%，融券余 额下降7.01%。 从机构评级来看，近一个月该股获1家机构买入评级。12月25日西部证券发布的研报给予公司增持评 级。 （文章来源：证券时报网） ...